These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 37157938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
    D'Antonio F, Marinceu D, Prasad S, Khalil A.
    Ultrasound Obstet Gynecol; 2023 Apr; 61(4):436-444. PubMed ID: 36484439
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention strategies for congenital cytomegalovirus infection.
    Tol I, Heath PT, Khalil A.
    Curr Opin Infect Dis; 2021 Oct 01; 34(5):546-551. PubMed ID: 34334662
    [Abstract] [Full Text] [Related]

  • 12. Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy.
    Nigro G, Muselli M, On Behalf Of The Congenital Cytomegalic Disease Collaborating Group.
    Viruses; 2023 Jun 15; 15(6):. PubMed ID: 37376675
    [Abstract] [Full Text] [Related]

  • 13. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
    Leruez-Ville M, Ghout I, Bussières L, Stirnemann J, Magny JF, Couderc S, Salomon LJ, Guilleminot T, Aegerter P, Benoist G, Winer N, Picone O, Jacquemard F, Ville Y.
    Am J Obstet Gynecol; 2016 Oct 15; 215(4):462.e1-462.e10. PubMed ID: 27083761
    [Abstract] [Full Text] [Related]

  • 14. Current practices of management of maternal and congenital Cytomegalovirus infection during pregnancy after a maternal primary infection occurring in first trimester of pregnancy: Systematic review.
    Périllaud-Dubois C, Belhadi D, Laouénan C, Mandelbrot L, Picone O, Vauloup-Fellous C.
    PLoS One; 2021 Oct 15; 16(12):e0261011. PubMed ID: 34860861
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combined treatment with immunoglobulin and valaciclovir in pregnant women with cytomegalovirus infection and high risk of symptomatic fetal disease.
    De la Calle M, Baquero-Artigao F, Rodríguez-Molino P, Cabanes M, Cabrera M, Antolin E, Mellado MJ, Bartha JL.
    J Matern Fetal Neonatal Med; 2022 Aug 15; 35(16):3196-3200. PubMed ID: 32933353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
    Kagan KO, Enders M, Hoopmann M, Geipel A, Simonini C, Berg C, Gottschalk I, Faschingbauer F, Schneider MO, Ganzenmueller T, Hamprecht K.
    Ultrasound Obstet Gynecol; 2021 Apr 15; 57(4):560-567. PubMed ID: 33491819
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study.
    Karofylakis E, Thomas K, Kavatha D, Galani L, Tsiodras S, Giamarellou H, Papaevangelou V, Antoniadou A.
    Viruses; 2024 Aug 02; 16(8):. PubMed ID: 39205215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.